InterOcean Capital Group’s iShares Biotechnology ETF IBB Stock Holding History

InterOcean Capital Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$2.55M	Sell	18,578 -3,935	-17%	-$537K	0.06%	142
2023 Q4	$3.06M	Sell	22,513 -5,703	-20%	-$696K	0.08%	124
2023 Q3	$3.45M	Sell	28,216 -1,151	-4%	-$146K	0.11%	111
2023 Q2	$3.73M	Buy	29,367 +269	+0.9%	+$34.9K	0.12%	101
2023 Q1	$3.76M	Sell	29,098 -566	-2%	-$74.1K	0.13%	100
2022 Q4	$3.89M	Buy	29,664 +4,833	+19%	+$625K	0.14%	103
2022 Q3	$2.9M	Sell	24,831 -5,440	-18%	-$676K	0.12%	102
2022 Q2	$3.56M	Buy	30,271 +19,131	+172%	+$2.27M	0.14%	87
2022 Q1	$1.45M	Buy	11,140 +4,459	+67%	+$581K	0.06%	101
2021 Q4	$1.02M	Buy	+6,681	New	+$1.03M	0.04%	121

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

InterOcean Capital Group's IBB Position: Q1 2024 in Review

InterOcean Capital Group reduced its iShares Biotechnology ETF (IBB) stake by 17% in Q1 2024, selling an estimated $537K and leaving 18,578 shares worth $2.55M. The position accounts for 0.06% of the portfolio, ranked #142.

InterOcean Capital Group first reported a position in IBB in Q4 2021 and has held it in 10 quarters since. The position peaked at $3.89M in Q4 2022. 901 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

InterOcean Capital Group held 18,578 shares of iShares Biotechnology ETF worth $2.55M as of Q1 2024.
InterOcean Capital Group sold 3,935 iShares Biotechnology ETF shares in Q1 2024, an estimated $537K.
iShares Biotechnology ETF made up 0.06% of InterOcean Capital Group's portfolio in Q1 2024, its #142 holding.
InterOcean Capital Group first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 10 quarters since.
InterOcean Capital Group's iShares Biotechnology ETF position peaked at $3.89M in Q4 2022.
901 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.